Mustang Bio, Inc. Share Price

Mustang Bio, Inc. Share Price

NASDAQ: MBIO | Micro Cap
$0.43
+$0.05 (12.91%) Last updated on 30 Oct, 2026 | 23:36 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Mustang Bio, Inc. Stock Performance

Open
$0.40
Prev. Close
$0.38
Circuit Range
N/A
Day Range
$0.40 - $0.43
Year Range
$0.37 - $1.47
Volume
300
Average Traded
$0.42

Mustang Bio, Inc. Share Price Today

As of 31 October 2026, Mustang Bio, Inc.'s share price is $0.43. The stock opened at $0.40, compared to its previous close of $0.38. During today's trading session, Mustang Bio, Inc.'s share price traded between $0.40 and $0.43, with an average price of $0.41. Over the past 52 weeks, the stock has recorded a high of $1.47 and a low of $0.37. In terms of performance, Mustang Bio, Inc.'s share price has declined by 42.40% over the last six months and is down 70.77% on a year-on-year basis.

Mustang Bio, Inc. Share Price Chart

Line chart of the Mustang Bio, Inc. price trend over the selected period. The price rose overall, ranging from 0.40 to 0.43, ending at 0.43.
$0.40$0.43
L
Show Current Price
H

Mustang Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.09M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.40
Revenue (TTM)
$0.00
Return On Equity (TTM)
-40.20%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-127.66%

Mustang Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$0.47-$0.54-$0.96-$1.07
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.89%-77.78%-11.46%

Mustang Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$77.53-$51.60-$15.75-$1.92
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A33.45%69.48%87.81%

About Mustang Bio, Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Mustang Bio, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.46
$0.43
-18.39%
Sep 2026
$0.55
$0.52
-6.79%
Aug 2026
$0.57
$0.56
-5.08%
Jul 2026
$0.70
$0.59
-15.11%
Jun 2026
$0.73
$0.69
+4.67%
May 2026
$0.75
$0.66
-10.39%
Apr 2026
$0.73
$0.74
+1.09%
Mar 2026
$0.91
$0.73
-28.14%
Feb 2026
$0.98
$1.02
+2.31%
Jan 2026
$1.05
$1.00
+1.22%
Dec 2025
$1.36
$0.98
-30.14%
Nov 2025
$1.41
$1.41
-3.42%

MBIO Share Price FAQs